Skip to content
OpenCapital
Get started

Charles River Laboratories CRL RMS — SG&A

Other segment segments

DSA
$47.52M-27.2%
Manufacturing
$29.71M-12.7%

Similar metrics at other companies

IQVIA logo
IQVResearch & Development Solutions — Selling, general and administrative expenses
$250M+8.7%
Arrowhead Research logo
ARWROperating Segment — SG&A
$41.74M+47.0%
Flex Ltd. logo
FLEXRMS — Selling, General And Administrative Expense, Adjusted
$88.75M+10.2%
RB Global logo
RBAOperating Segments — Selling General And Administrative Expense
$101.26M+36.1%
Kimberly-Clark logo
KMBIPC — Research, Selling and General Expense
$168M-2.9%
CSL
CSLReportable Segments — Selling and administrative expenses
$160.43M+6.8%

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%—
Operating margin13%-2.4pp
Net margin-4.6%—
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%—
Debt / equity1×+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's rms — sg&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's RMS — SG&A?
Charles River Laboratories (CRL) reported RMS — SG&A of $1.6M in Q1 2026.
How has Charles River Laboratories's RMS — SG&A changed year-over-year?
Charles River Laboratories's RMS — SG&A decreased by 93.4% year-over-year, from $24.21M to $1.6M.
What is the long-term trend for Charles River Laboratories's RMS — SG&A?
Over 3 years (2022 to 2025), Charles River Laboratories's RMS — SG&A has grown at a -0.4% compound annual growth rate (CAGR), from $102.8M to $101.53M.
What does RMS — SG&A mean?
The indirect operating costs required to manage and support the segment's business activities.
How do you interpret RMS — SG&A?
A decrease relative to revenue indicates improved administrative efficiency, whereas a sustained increase may suggest rising overhead or aggressive investment in market expansion.
How does RMS — SG&A compare across companies?
Comparable to SG&A expense allocations for business units within diversified healthcare or research services firms.